These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 25335832)

  • 1. The need for multipurpose prevention technologies in sub-Saharan Africa.
    Karim SA; Baxter C; Frohlich J; Karim QA
    BJOG; 2014 Oct; 121 Suppl 5(0 5):27-34. PubMed ID: 25335838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collegiate Women's Definitions of Responsible Sexual Behavior.
    Loew N; Lehan Mackin M; Ayres L
    West J Nurs Res; 2018 Aug; 40(8):1148-1162. PubMed ID: 28470114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intervention based on the 5A self-management model on the improvement of behaviors related to women's reproductive health after legal abortion.
    Mirian Z; AbdiShahshahani M; Noroozi M; Mostafavi F; Beigi M
    Sci Rep; 2023 Jul; 13(1):11316. PubMed ID: 37443384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bridging the gap: advancing multipurpose prevention technologies from the lab into the hands of women†.
    Young Holt B; Kiarie J; Kopf GS; Nanda K; Hemmerling A; Achilles SL
    Biol Reprod; 2020 Aug; 103(2):286-288. PubMed ID: 32657337
    [No Abstract]   [Full Text] [Related]  

  • 5. Engineering monoclonal antibody-based contraception and multipurpose prevention technologies†.
    Anderson DJ; Politch JA; Cone RA; Zeitlin L; Lai SK; Santangelo PJ; Moench TR; Whaley KJ
    Biol Reprod; 2020 Aug; 103(2):275-285. PubMed ID: 32607584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing multipurpose reproductive health technologies: an integrated strategy.
    Harrison PF; Hemmerling A; Romano J; Whaley KJ; Young Holt B
    AIDS Res Treat; 2013; 2013():790154. PubMed ID: 23533733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. End-to-end approach to ensuring equitable access to multipurpose prevention technologies in low- and middle-income countries.
    Cameron AI; Scott C; Pérez-Casas C; Barker T
    Front Reprod Health; 2023; 5():1238813. PubMed ID: 37711397
    [No Abstract]   [Full Text] [Related]  

  • 8. Messenger RNA Therapy for Female Reproductive Health.
    VanKeulen-Miller R; Fenton OS
    Mol Pharm; 2024 Feb; 21(2):393-409. PubMed ID: 38189262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial: Multipurpose prevention technologies: call for innovative strategies to address critical priorities and gaps.
    Soh C; van der Straten A; Hemmerling A; Turpin JA; Young Holt B
    Front Reprod Health; 2024; 6():1417974. PubMed ID: 38827819
    [No Abstract]   [Full Text] [Related]  

  • 10. "We are not the same": African women's view of multipurpose prevention products in the TRIO clinical study.
    Shapley-Quinn MK; Manenzhe KN; Agot K; Minnis AM; van der Straten A
    Int J Womens Health; 2019; 11():97-107. PubMed ID: 30799959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women.
    Thurman AR; Schwartz JL; Brache V; Clark MR; McCormick T; Chandra N; Marzinke MA; Stanczyk FZ; Dezzutti CS; Hillier SL; Herold BC; Fichorova R; Asin SN; Rollenhagen C; Weiner D; Kiser P; Doncel GF
    PLoS One; 2018; 13(6):e0199778. PubMed ID: 29953547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syphilis Elimination: Lessons Learned Again.
    Valentine JA; Bolan GA
    Sex Transm Dis; 2018 Sep; 45(9S Suppl 1):S80-S85. PubMed ID: 29596223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlling the hydration rate of a hydrophilic matrix in the core of an intravaginal ring determines antiretroviral release.
    Teller RS; Malaspina DC; Rastogi R; Clark JT; Szleifer I; Kiser PF
    J Control Release; 2016 Feb; 224():176-183. PubMed ID: 26723526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multipurpose prevention technologies: the future of HIV and STI protection.
    Fernández-Romero JA; Deal C; Herold BC; Schiller J; Patton D; Zydowsky T; Romano J; Petro CD; Narasimhan M
    Trends Microbiol; 2015 Jul; 23(7):429-436. PubMed ID: 25759332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ensuring successful development and introduction of multipurpose prevention technologies through an innovative partnership approach.
    Young Holt B; Romano J; Manning J; Hemmerling A; Shields W; Vyda L; Lusti-Narasimhan M
    BJOG; 2014 Oct; 121 Suppl 5():3-8. PubMed ID: 25335832
    [No Abstract]   [Full Text] [Related]  

  • 16. Making the case for multipurpose prevention technologies: the socio-epidemiological rationale.
    Boonstra H; Barot S; Lusti-Narasimhan M
    BJOG; 2014 Oct; 121 Suppl 5():23-6. PubMed ID: 25335837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond HIV microbicides: multipurpose prevention technology products.
    Malcolm RK; Boyd P; McCoy CF; Murphy DJ
    BJOG; 2014 Oct; 121 Suppl 5():62-9. PubMed ID: 25335842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aligning product development and user perspectives: social-behavioural dimensions of multipurpose prevention technologies.
    Brady M; Tolley E
    BJOG; 2014 Oct; 121 Suppl 5():70-8. PubMed ID: 25335843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons from reproductive health to inform multipurpose prevention technologies: don't reinvent the wheel.
    Brady M; Manning J
    Antiviral Res; 2013 Dec; 100 Suppl():S25-31. PubMed ID: 24188700
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.